Literature DB >> 8827718

Engagement of tumor necrosis factor mRNA by an endotoxin-inducible cytoplasmic protein.

C Gueydan1, L Houzet, A Marchant, A Sels, G Huez, V Kruys.   

Abstract

BACKGROUND: Tumor necrosis factor (TNF) production by macrophages plays an important role in the host response to infection. TNF-alpha gene expression in RAW 264.7 macrophages is predominantly regulated at the translational level. A key element in this regulation is an AU-rich (AUR) sequence located in the 3' untranslated region (UTR) of TNF mRNA. In unstimulated macrophages, the translation of TNF mRNA is inhibited via this AUR sequence. Upon stimulation with LPS, this repression is overcome and translation occurs. In this study, we attempted to identify cellular proteins that interact with the AUR sequence and thereby regulate TNF mRNA translation.
MATERIALS AND METHODS: RNA probes corresponding to portions of TNF mRNA 3' UTR were synthesized. These labeled RNAs were incubated with cytoplasmic extracts of either unstimulated or lipopolysaccharides (LPS)-stimulated RAW 264.7 macrophages. The RNA/protein complexes formed were analyzed by gel retardation. Ultraviolet (UV) cross-linking experiments were performed to determine the molecular weight of the proteins involved in the complexes.
RESULTS: TNF mRNA AUR sequence formed two complexes (1 and 2) of distinct electrophoretic mobilities. While the formation of complex 1 was independent of the activation state of the macrophages from which the extracts were obtained, complex 2 was detected only using cytoplasmic extracts from LPS-stimulated macrophages. Upon UV cross-linking, two proteins, of 50 and 80 kD, respectively, were capable of binding the UAR sequence. The 50-kD protein is likely to be part of the LPS-inducible complex 2, since its binding ability was enhanced upon LPS stimulation. Interestingly, complex 2 formation was also triggered by Sendaï virus infection, another potent activator of TNF mRNA translation in RAW 264.7 macrophages. In contrast, complex 2 was not detected with cytoplasmic extracts obtained from B and T cell lines which are unable to produce TNF in response to LPS. Protein tyrosine phosphorylation is required for LPS-induced TNF mRNA translation. Remarkably, the protein tyrosine phosphorylation inhibitor herbimycin A abolished LPS-induced complex 2 formation. Complex 2 was already detectable after 0.5 hr of LPS treatment and was triggered by a minimal LPS dose of 10 pg/ml.
CONCLUSIONS: The tight correlation between TNF production and the formation of an LPS-inducible cytoplasmic complex suggests that this complex plays a role in the translational regulation of TNF mRNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827718      PMCID: PMC2230167     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  31 in total

Review 1.  Regulated mRNA stability.

Authors:  J A Atwater; R Wisdom; I M Verma
Journal:  Annu Rev Genet       Date:  1990       Impact factor: 16.830

2.  An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA.

Authors:  P R Bohjanen; B Petryniak; C H June; C B Thompson; T Lindsten
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

3.  A 32-kilodalton protein binds to AU-rich domains in the 3' untranslated regions of rapidly degraded mRNAs.

Authors:  E Vakalopoulou; J Schaack; T Shenk
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

4.  Identification of an AUUUA-specific messenger RNA binding protein.

Authors:  J S Malter
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

5.  Translational blockade imposed by cytokine-derived UA-rich sequences.

Authors:  V Kruys; O Marinx; G Shaw; J Deschamps; G Huez
Journal:  Science       Date:  1989-08-25       Impact factor: 47.728

6.  A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.

Authors:  B Beutler; T Brown
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

7.  Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages.

Authors:  S L Weinstein; M R Gold; A L DeFranco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

8.  Identification of a translation inhibitory element (TIE) in the 3' untranslated region of the human interferon-beta mRNA.

Authors:  V I Kruys; M G Wathelet; G A Huez
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

9.  An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro.

Authors:  G Brewer
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

10.  Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level.

Authors:  J Han; T Brown; B Beutler
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

View more
  11 in total

1.  A GG nucleotide sequence of the 3' untranslated region of amyloid precursor protein mRNA plays a key role in the regulation of translation and the binding of proteins.

Authors:  E G Mbella; S Bertrand; G Huez; J N Octave
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Masking, unmasking, and regulated polyadenylation cooperate in the translational control of a dormant mRNA in mouse oocytes.

Authors:  A Stutz; B Conne; J Huarte; P Gubler; V Völkel; P Flandin; J D Vassalli
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

3.  The 3' untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR.

Authors:  J L Dean; R Wait; K R Mahtani; G Sully; A R Clark; J Saklatvala
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  Characterization of the RNA binding proteins forming complexes with a novel putative regulatory region in the 3'-UTR of TNF-alpha mRNA.

Authors:  Z Hel; S Di Marco; D Radzioch
Journal:  Nucleic Acids Res       Date:  1998-06-01       Impact factor: 16.971

5.  Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism.

Authors:  Zoltán H Németh; Carol S Lutz; Balázs Csóka; Edwin A Deitch; S Joseph Leibovich; William C Gause; Masahide Tone; Pál Pacher; E Sylvester Vizi; György Haskó
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

6.  Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.

Authors:  W S Lai; E Carballo; J R Strum; E A Kennington; R S Phillips; P J Blackshear
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

7.  TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha.

Authors:  M Piecyk; S Wax; A R Beck; N Kedersha; M Gupta; B Maritim; S Chen; C Gueydan; V Kruys; M Streuli; P Anderson
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

8.  Polymorphism in the 3'-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA.

Authors:  S Di Marco; Z Hel; C Lachance; H Furneaux; D Radzioch
Journal:  Nucleic Acids Res       Date:  2001-02-15       Impact factor: 16.971

9.  The RNA-binding protein tristetraprolin regulates RALDH2 expression by intestinal dendritic cells and controls local Treg homeostasis.

Authors:  Caroline La; Bérengère de Toeuf; Laure B Bindels; Laurye Van Maele; Assiya Assabban; Maxime Melchior; Justine Smout; Arnaud Köhler; Muriel Nguyen; Séverine Thomas; Romuald Soin; Nadège Delacourt; Hsüehlei Li; Wenqian Hu; Perry J Blackshear; Véronique Kruys; Cyril Gueydan; Guillaume Oldenhove; Stanislas Goriely
Journal:  Mucosal Immunol       Date:  2020-05-28       Impact factor: 8.701

10.  ARE-mediated decay controls gene expression and cellular metabolism upon oxygen variations.

Authors:  Bérengère de Toeuf; Romuald Soin; Abdelkarim Nazih; Marija Dragojevic; Dukas Jurėnas; Nadège Delacourt; Long Vo Ngoc; Abel Garcia-Pino; Véronique Kruys; Cyril Gueydan
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.